HYPD
NASDAQ
US
Hyperion DeFi, Inc. - Common Stock
$3.25
▼ $-0.02
(-0.61%)
Vol 454K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$29.1M
ROE
9.4%
Margin
-4868.7%
D/E
10.82
Beta
3.81
52W
$3–$16
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 60.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-4.71 | $-7.76 | $-3.05 |
| Mar 2025 | $-9.79 | $-1.63 | +$8.16 |
| Dec 2024 | $-7.34 | $-6.93 | +$0.41 |
| Sep 2024 | $-10.88 | $-8.80 | +$2.08 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $2K | $28K | $15K | — | $303K |
| Net Income | -$7.9M | -$20.0M | -$3.5M | -$8.7M | $6.6M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -552.6% | -552.6% | -552.6% | -552.6% | 9.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -63187.5% | -63187.5% | -63187.5% | -63187.5% | -4868.7% |
| Gross Margin | — | -5452.8% | -5452.8% | -5452.8% | -5452.8% | -798.1% |
| D/E Ratio | 20.12 | 311.10 | 20.12 | 20.12 | 20.12 | 10.82 |
| Current Ratio | 0.91 | 0.34 | 0.91 | 0.91 | 0.91 | 2.25 |
Key Ratios
ROA (TTM)
-54.6%
P/S (TTM)
84.25
EPS (TTM)
$-17.80
Rev Growth 3Y
-84.0%
52W High
$16.35
52W Low
$2.91
$2.91
52-Week Range
$16.35
Financial Health
Free Cash Flow
-$22.9M
Net Debt
$269K
Cash
$8.2M
Total Debt
$8.5M
As of Sep 30, 2025
How does HYPD compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
HYPD valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
84.3
▲
1602%
above
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
HYPD profitability vs Pharmaceuticals peers
ROE
9.4%
▲
117%
above
peers
(-54.3%)
vs Peers
vs Industry
Top tier
Net margin
-4868.7%
▼
10178%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
-798.1%
▼
1268%
below
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-54.6%
▼
46%
below
peers
(-37.4%)
vs Peers
vs Industry
Below avg
HYPD financial health vs Pharmaceuticals peers
D/E ratio
10.8
▲
603%
above
peers
(1.5)
vs Peers
vs Industry
Above avg
Current ratio
2.3
▼
33%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
3.8
▲
305%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
HYPD fundamentals radar
HYPD
Peer median
Industry
HYPD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
HYPD vs peers: key metrics
Latest News
No related news yet